Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial-Reference-Cited by-同舟云学术

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Published:2009-03 Issue:3 Volume:181 Page:956-962
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Thompson Ian M.¹,Tangen Catherine M.²,Paradelo Jorge³,Lucia M. Scott⁴,Miller Gary⁴,Troyer Dean¹,Messing Edward⁵,Forman Jeffrey⁶,Chin Joseph⁷,Swanson Gregory¹,Canby-Hagino Edith⁸,Crawford E. David⁴

Affiliation:

1. University of Texas Health Science Center at San Antonio, San Antonio, Texas

2. The Fred Hutchinson Cancer Research Center, Seattle, Washington

3. The Kansas City Community Clinical Oncology Program, Kansas City, Missouri

4. The University of Colorado Health Science Center, Denver, Colorado

5. The James P. Wilmot Cancer Center, University of Rochester School of Medicine, Rochester, New York

6. Wayne State University School of Medicine, Detroit, Michigan

7. University of Western Ontario, Department of Surgical Oncology, London, Ontario

8. Wilford Hall Medical Center, San Antonio, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject